News

A company that has Donald Trump Jr. on its board touted in a press release a new “initiative” to help pharmaceutical ...
Ministers are preparing to boost NHS spending on US drugs in a race to avoid a future tariff hit from Donald Trump.
Tesla’s board is giving Chief Executive Elon Musk a $23.7 billion stock award —so long as he stays focused on the company.
Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...
Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...
Tánaiste Simon Harris has said the introduction of the new US tariff on EU goods provides "some degree of certainty" to businesses.
Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
The dividend yield investors could receive from Pfizer stock has risen from about 3% in early 2022 to 7% when the market ...
Former Gov. Andrew M. Cuomo acknowledged that he had not run an effective race in the mayoral primary and asked for executives’ help to defeat Zohran Mamdani.
Pfizer CEO Albert Bourla said his company is in “very active discussions” over Trump’s request concerning most-favoured-nation pricing, according to news website FiercePharma. Bourla said he had ...
PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.